Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.10.2023 | Case report

Doxorubicin/ifosfamide

Haematologic toxicities: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Willner A, et al. Chemoradiotherapy plus hyperthermia (CRTH) versus chemoradiotherapy (CRT) alone in neoadjuvant treatment of soft tissue sarcoma: tumor response, treatment toxicity and disease control. International Journal of Hyperthermia 40: No. 1, 2023. Available from: URL: http://doi.org/10.1080/02656736.2023.2248424 Willner A, et al. Chemoradiotherapy plus hyperthermia (CRTH) versus chemoradiotherapy (CRT) alone in neoadjuvant treatment of soft tissue sarcoma: tumor response, treatment toxicity and disease control. International Journal of Hyperthermia 40: No. 1, 2023. Available from: URL: http://​doi.​org/​10.​1080/​02656736.​2023.​2248424
Metadaten
Titel
Doxorubicin/ifosfamide
Haematologic toxicities: case report
Publikationsdatum
01.10.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-47205-x

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Adalimumab

Case report

Sevoflurane